Literature DB >> 2886174

Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.

A G Dupont, R A Lefebvre, P Vanderniepen.   

Abstract

The effect of local administration of the dopamine 2 (DA2)-receptor agonist quinpirole and of the DA1-receptor agonist fenoldopam was studied in the in situ, constant flow autoperfused, superior mesenteric vascular bed of the rat. Local infusion of quinpirole (30 micrograms kg-1 min-1 for 5 min) had no effect on baseline perfusion pressure; it reduced the pressor responses to electrical stimulation (4 Hz, 1 ms, supramaximal voltage) of the periarterial sympathetic nerves to 45.6 +/- 2.1% of its original value but did not modify similar pressor responses produced by locally administered noradrenaline. The inhibitory effect of quinpirole was antagonized by the selective DA2-receptor antagonist domperidone (10 micrograms kg-1) but not by the selective DA1-receptor antagonist SCH 23390 (50 micrograms kg-1). Local infusion of fenoldopam (30 micrograms kg-1 min-1 for 5 min) reduced baseline perfusion pressure to 89.9 +/- 1.9%, increased the pressor response to electrical stimulation (4 Hz, 1 ms, supramaximal voltage) of the periarterial nerves to 134.7 +/- 14.0%, but reduced the pressor response to locally administered noradrenaline to 37.2 +/- 8.2%. Similar pressor responses induced by the selective alpha 1-adrenoceptor agonist phenylephrine were also reduced by fenoldopam (to 38.4 +/- 6.4%), but responses to locally administered angiotensin II were not modified. Pretreatment with SCH 23390 (50 micrograms kg-1) antagonized the effect of fenoldopam on baseline perfusion pressure, but had no influence on the effect of fenoldopam on responses to electrical stimulation or to noradrenaline. Pretreatment with the selective alpha 2-adrenoceptor antagonist rauwolscine (100 micrograms kg-1) had no effect on the reduction in baseline perfusion pressure induced by fenoldopam nor on its inhibitory effect on the response to noradrenaline, but it antagonized the stimulatory effect of fenoldopam on the response to electrical stimulation. 7 The results show that quinpirole inhibits neurogenic vasoconstriction in the rat superior mesenteric vascular bed through stimulation of presynaptic DA2-receptors while fenoldopam stimulates postsynaptic vasodilatory DA,-receptors. In addition, our results suggest that the inhibitory effect of fenoldopam on the vasoconstrictor response to noradrenaline may be due to an antagonistic action at postsynaptic alpha-adrenoceptors, while its potentiating effect on neurogenic vasoconstriction is due to blockade of presynaptic alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886174      PMCID: PMC1853536          DOI: 10.1111/j.1476-5381.1987.tb11242.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Pharmacological characterization of neuronal dopamine receptors in the rat hindquarters, renal and superior mesenteric vascular beds.

Authors:  A G Dupont; P Vanderniepen; R A Lefebvre; M G Bogaert
Journal:  J Auton Pharmacol       Date:  1986-12

2.  Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.

Authors:  E H Ohlstein; B Zabko-Potapovich; B A Berkowitz
Journal:  J Pharmacol Exp Ther       Date:  1984-05       Impact factor: 4.030

3.  SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors.

Authors:  A Hilditch; G M Drew; R J Naylor
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

4.  Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.

Authors:  R W Lappe; J A Todt; R L Wendt
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

5.  Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.

Authors:  A Hilditch; G M Drew
Journal:  Eur J Pharmacol       Date:  1985-10-08       Impact factor: 4.432

6.  Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

Authors:  R A Hahn; J R Wardell; H M Sarau; P T Ridley
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

7.  Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.

Authors:  R A Hahn; B R MacDonald
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

8.  The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission.

Authors:  E K Jackson; W B Campbell
Journal:  Eur J Pharmacol       Date:  1980-08-29       Impact factor: 4.432

9.  Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.

Authors:  J D Kohli; D Glock; L I Goldberg
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

10.  Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat.

Authors:  A J Nichols; C R Hiley
Journal:  J Pharm Pharmacol       Date:  1985-02       Impact factor: 3.765

View more
  8 in total

1.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.

Authors:  P H Van der Graaf; P R Saxena; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.

Authors:  J C Wanstall; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

Review 4.  Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.

Authors:  R N Brogden; A Markham
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

5.  Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

Authors:  L C Rump; K Wilde; C Bohmann; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

6.  Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit.

Authors:  J Davidson; A S Milton; D Rotondo
Journal:  J Physiol       Date:  1992       Impact factor: 5.182

7.  Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.

Authors:  D F Schoors; G P Vauquelin; H De Vos; G Smets; B Velkeniers; L Vanhaelst; A G Dupont
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

8.  The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.